BLOG
/
Drug Information

Atorvastatin vs Rosuvastatin: Which Statin Is Right for You?

Written by
Reviewed by
Michael Chen, MD
Published
April 18, 2026
Key Takeaways
  • Rosuvastatin tends to lower LDL cholesterol a little more than atorvastatin at comparable doses, based on the STELLAR trial.
  • Atorvastatin goes through CYP3A4 and is affected by grapefruit and some antibiotics and antifungals; rosuvastatin barely uses CYP enzymes.
  • Atorvastatin does not need kidney-based dose adjustment; rosuvastatin is capped at 10 mg daily in severe CKD.
  • The SAMSON trial showed about 90% of muscle symptoms attributed to statins also appeared on placebo, pointing to a strong nocebo effect.
  • Both drugs are generic, long half-life, and can be taken any time of day, so adherence and fit with your other medications matter as much as the molecule itself.

Atorvastatin vs Rosuvastatin: The Short Answer

Atorvastatin (Lipitor) and rosuvastatin (Crestor) are both long half-life statins that lower LDL cholesterol and cardiovascular risk. Rosuvastatin tends to lower LDL a little more at comparable doses. Atorvastatin has a broader dose range and is usually preferred in chronic kidney disease. The right choice for you depends on your LDL target, your kidney function, the other medications you take, and how your body reacts.

Why This Comparison Matters

Statins are one of the most prescribed medication classes in the United States, and atorvastatin and rosuvastatin are the two most common high-intensity options. They look similar on paper. The differences show up in how they are broken down by the liver, how they interact with food and other drugs, and how they are dosed for specific groups of patients.

Adherence is a practical concern too. Data summarized in the Journal of the American Heart Association show many adults stop taking their statin within a year of starting. Picking a statin that fits your routine and your body, and knowing what side effects are actually likely, can make staying on therapy easier.

Head-to-Head Comparison

FeatureAtorvastatin (Lipitor)Rosuvastatin (Crestor)
Drug classHMG-CoA reductase inhibitor (statin)HMG-CoA reductase inhibitor (statin)
Dose range10 to 80 mg once daily5 to 40 mg once daily
Plasma half-life~14 hours (active metabolites extend effect 20 to 30 hours)~19 hours
Main metabolismCYP3A4 (extensive)Minimal CYP; about 10% via CYP2C9
SolubilityLipophilicHydrophilic
Food / timingWith or without food, any time of dayWith or without food, any time of day
GrapefruitAvoid large amounts (more than about 1.2 L/day)No meaningful grapefruit effect
CKD (eGFR <30)No dose adjustmentStart 5 mg, max 10 mg/day
Generic availableYesYes

Sources: Lipitor (atorvastatin) DailyMed label and rosuvastatin calcium DailyMed label.

How They Compare on LDL Reduction

The cleanest head-to-head data come from the STELLAR trial (Jones 2003), a six-week randomized study of 2,431 adults with high cholesterol. Across the 10 to 80 mg dose range, rosuvastatin lowered LDL cholesterol by a mean of 8.2% more than atorvastatin (p<0.001). LDL treatment goals were reached by 82 to 89% of people on rosuvastatin 10 to 40 mg, compared with 69 to 85% of people on atorvastatin 10 to 80 mg.

A common clinician shorthand is that rosuvastatin 10 mg produces roughly similar LDL lowering to atorvastatin 20 mg, though individual response varies quite a bit. If your LDL target is aggressive, rosuvastatin may reach it at a lower milligram dose. If your LDL is already close to goal, the difference between the two is small.

How They Compare on Drug and Food Interactions

This is where the two statins really diverge.

Atorvastatin is extensively broken down by CYP3A4, a liver enzyme that handles a lot of common prescriptions. Drugs and foods that block CYP3A4 can raise atorvastatin levels in your blood and increase the risk of muscle side effects. The FDA label specifically advises against "more than 1.2 liters daily" of grapefruit juice with atorvastatin. Macrolide antibiotics like clarithromycin, certain azole antifungals like itraconazole, and some HIV protease inhibitors also raise atorvastatin exposure.

Rosuvastatin barely uses CYP enzymes. About 90% of its activity comes from the parent drug, and only about 10% is metabolized, mostly through CYP2C9. That means grapefruit, clarithromycin, and most CYP3A4 inhibitors do not meaningfully change rosuvastatin levels. The main interactions for rosuvastatin instead come from drugs (like cyclosporine or certain HIV and hepatitis C medicines) that block OATP1B1, a transporter protein that pulls statins from the bloodstream into the liver where they work.

If you take several medications, especially ones that run through CYP3A4, rosuvastatin is often the cleaner choice. If your medication list is simpler and you rarely drink grapefruit juice, atorvastatin is rarely a problem.

Muscle Side Effects and the Nocebo Effect

Both statins list muscle pain (myalgia) and the rare but serious complication rhabdomyolysis in their labels. People often assume a statin is the cause of any new muscle ache.

The SAMSON trial (Howard 2021, JACC) tested that assumption. Sixty patients who had stopped statins because of side effects took rotating months of atorvastatin, placebo, and no pill, scoring symptoms daily. Mean symptom scores were 16.3 on statin months and 15.4 on placebo months, with no statistically significant difference (p=0.388). The nocebo ratio was 0.90, meaning about 90% of symptoms attributed to the statin also appeared on placebo.

This does not mean muscle symptoms are imaginary. Pain is real, whatever causes it. The finding is that many people who could tolerate a statin give up based on expected side effects rather than true drug-related ones. If you had a reaction to one statin, switching to the other, or trying a lower dose or an alternate-day schedule, is often worth discussing with your prescriber before giving up on statin therapy entirely.

Special Situations

Chronic kidney disease

For atorvastatin, the DailyMed label says no kidney-based dose adjustment is needed. For rosuvastatin, the DailyMed label sets a starting dose of 5 mg and a ceiling of 10 mg daily when creatinine clearance is below 30 mL/min/1.73m² and the patient is not on hemodialysis. The KDIGO lipid guidance reflects the same pattern, which is why atorvastatin is often preferred in advanced kidney disease.

Asian ancestry

The rosuvastatin label recommends starting at 5 mg once daily for Asian patients because pharmacokinetic studies showed about a two-fold higher median exposure compared with White subjects. Atorvastatin does not include a population-specific starting dose of this kind.

Pharmacogenomics (SLCO1B1)

A smaller group of people carry reduced-function variants in the SLCO1B1 gene, which codes for OATP1B1, the transporter that moves statins from the blood into liver cells. The 2022 CPIC guideline recommends considering lower doses or alternate statins for certain genotypes to reduce muscle side-effect risk. Both atorvastatin and rosuvastatin are named in that guideline, with specific dose-action thresholds that differ by genotype. Genetic testing is not routine, but your prescriber may consider it if you have had muscle symptoms on more than one statin.

Timing, Missed Doses, and Daily Routine

Both drugs are long half-life statins, so you can take either one at any time of day. Atorvastatin's plasma half-life is about 14 hours, but its effect on cholesterol production lasts 20 to 30 hours because of active metabolites. Rosuvastatin's half-life is about 19 hours. That flexibility is different from older statins like simvastatin, which work best at bedtime.

If you miss a dose, standard patient-counseling guidance for atorvastatin is to take it as soon as you remember, unless it is close to the time of your next dose. For details, see our guides on what to do if you miss a dose of atorvastatin and missed-dose guidance for rosuvastatin. For practical timing tips, our pieces on the best time to take atorvastatin and the best time to take rosuvastatin cover common questions. Curious about the CoQ10 question that comes up with either statin? Our article on whether statins deplete CoQ10 walks through what the evidence actually shows.

Which One Fits You Best?

Neither statin is universally "better." Here is a reasonable way to think about the decision.

Atorvastatin is often a good fit if you have advanced kidney disease, if your LDL target is moderate and already responds to standard doses, or if you want the widest possible dose range (10 to 80 mg).

Rosuvastatin often makes more sense if you need aggressive LDL lowering at a lower milligram dose, if your medication list includes several CYP3A4 substrates, or if you drink grapefruit juice regularly and would rather not give it up.

These are general patterns, not rules. Your prescriber weighs your full medical history alongside your labs and the other medications you take.

How Pillo Helps

Whichever statin you are on, staying consistent is what actually lowers cardiovascular risk over the long run. Pillo is a medication reminder app with persistent alarms that keep ringing until you take action, so your evening Lipitor or morning Crestor does not quietly get missed. You can log doses, track refills, and watch your adherence trend over time. Download Pillo on Google Play to set up a simple statin reminder that fits your routine.

FAQ

Is rosuvastatin stronger than atorvastatin?

In milligram for milligram terms, rosuvastatin generally produces a slightly larger LDL reduction. In the STELLAR trial, rosuvastatin lowered LDL cholesterol by a mean of 8.2% more than atorvastatin across the dose range. Both are considered high-intensity statins at higher doses.

Can I switch from atorvastatin to rosuvastatin or vice versa?

Yes, switching between statins is common and generally safe, but dose equivalence is not one-to-one. Your prescriber typically picks the new starting dose based on your LDL goal and overall cardiovascular risk. Talk to your prescriber about any changes before switching on your own.

Which statin has more side effects?

Large randomized trials show similar overall side-effect profiles. The SAMSON trial found that most muscle symptoms attributed to statins were also reported on placebo. That suggests expectation plays a large role in perceived tolerability. If you are having symptoms, they are still worth reporting to your prescriber.

Does grapefruit affect both statins equally?

No. Atorvastatin is metabolized by CYP3A4, which grapefruit inhibits, so the FDA label warns against large grapefruit intake. Rosuvastatin barely uses CYP3A4, so grapefruit is not a meaningful concern for it.

Are atorvastatin and rosuvastatin both generic?

Yes, both are available as generics in the United States, and generic pricing is comparable. Cost differences often come down to insurance formulary placement and pharmacy.

Medical Disclaimer

This article is for informational purposes only and does not constitute medical advice. Always consult your doctor or pharmacist before making any changes to your medication routine.

pillo-character-happy

Download Pillo
Free Today!

Scan the QR code
with your phone camera